Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT02238418
Eligibility Criteria:
Inclusion Criteria:
* Age : between \[18 mo et 18 yo\[
* Patients seen in the paediatric nephrology service and having :
* Chronic kidney disease
* Renal transplant
* Stable nephrotic syndrome (i.e., normal protidemia at inclusion)
* Initial 25 OH vitamin D concentration \< 75nmol/l
* Patient agree to participate (if old enough to give his agreement) and written informed consent signed by parents
* Patients affiliated within the French universal healthcare system
Exclusion Criteria:
\- Contraindication to 100 000 IU Uvedose® treatment (according to the Summary of Product Characteristics: known hypersensitivity to vitamin D or hypercalcemia, hypercalciuria or nephrolithiasis).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Months
Maximum Age:
18 Years
Study:
NCT02238418
Study Brief:
Protocol Section:
NCT02238418